U
HealthWarehouse.com, Inc. HEWA
$0.10 -$0.02-15.83% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

HealthWarehouse.com, Inc. (OTCQB: HEWA) is a U.S.-based online pharmacy and healthcare products retailer focused on prescription medications, over-the-counter products, pet medications, medical supplies, and wellness products. The company operates primarily through its licensed digital pharmacy platform, serving consumers seeking lower-cost pharmaceutical access through mail-order fulfillment. HealthWarehouse operates within the broader e-commerce healthcare, pharmacy services, and pharmaceutical distribution industries, with revenue primarily generated from prescription drug sales and consumer health product purchases through its online storefront.

The company positions itself as a transparent, cash-pay pharmacy alternative emphasizing competitive pricing and direct-to-consumer fulfillment. HealthWarehouse was founded in 2007 and developed as an internet-based pharmacy model during the expansion of online healthcare commerce in the United States. Public filings and company disclosures indicate the business has focused on regulatory compliance, nationwide pharmacy licensing, and customer acquisition through digital channels. The company has also emphasized accessibility for uninsured or underinsured consumers seeking non–pharmacy benefit manager pricing structures.

Business Operations

HealthWarehouse generates revenue primarily through online retail sales of prescription medications, generic drugs, branded pharmaceuticals, and health-related consumer products. Its operations are centered around its licensed pharmacy infrastructure, fulfillment capabilities, customer service operations, and proprietary e-commerce platform. The company’s activities are concentrated in the United States, where it ships medications and healthcare products directly to consumers in jurisdictions where it maintains required pharmacy licenses and regulatory approvals. Public disclosures identify prescription fulfillment and healthcare product sales as core operating activities rather than diversified industrial segments.

The company controls key assets including its online pharmacy platform, pharmacy licenses, fulfillment operations, customer databases, and regulatory infrastructure required for pharmaceutical dispensing. HealthWarehouse has historically emphasized partnerships with pharmaceutical wholesalers and suppliers to source inventory and maintain product availability. Publicly available information does not indicate a large international subsidiary network or extensive joint venture structure. Data regarding material international subsidiaries or major strategic joint ventures is inconclusive based on available public sources.

Strategic Position & Investments

HealthWarehouse’s strategic direction has centered on expanding digital pharmacy adoption, increasing prescription volume, and strengthening its position in the online healthcare retail market. Company disclosures and investor communications have highlighted efforts to improve technology infrastructure, enhance user experience, broaden prescription transfer capabilities, and increase operational efficiency in fulfillment and customer acquisition. The company has also promoted transparent pricing as a differentiator within the pharmacy market, particularly for generic medications and cash-pay consumers.

The company operates in sectors benefiting from broader healthcare digitization trends, including telehealth integration, e-commerce pharmacy distribution, and direct-to-consumer healthcare services. Public filings do not indicate major transformative acquisitions comparable to larger pharmacy chains or healthcare conglomerates. Available disclosures also do not identify a broad portfolio of subsidiaries or venture investments. While the company has participated in evolving online pharmacy and healthcare technology ecosystems, detailed information regarding material investments in emerging technologies remains limited in public filings.

Geographic Footprint

HealthWarehouse is headquartered in Kentucky, United States, and its operations are primarily focused on the U.S. domestic market. The company serves customers nationwide through mail-order fulfillment and maintains pharmacy licensing across multiple U.S. states as required for prescription dispensing. Its operational footprint is largely centralized around domestic e-commerce distribution rather than physical retail pharmacy locations.

The company’s market presence is concentrated in North America, particularly the United States, where regulatory compliance and fulfillment capabilities form the foundation of its business model. Publicly available records do not indicate substantial operational infrastructure outside the United States or major international investments. Although the company’s online platform may be accessible globally, available public disclosures primarily support a U.S.-focused operating strategy.

Leadership & Governance

HealthWarehouse leadership has historically emphasized regulatory compliance, consumer price transparency, and scalable digital pharmacy operations. Governance and operational oversight are guided through executive management and board leadership disclosed in company filings and OTC market disclosures. Strategic priorities communicated by management have included sustainable revenue growth, operational efficiency, and expansion of online pharmacy adoption among consumers seeking lower-cost medication alternatives.

Key executives identified through public company disclosures include:

  • Joseph Peters – Chairman and Chief Executive Officer
  • David Hach – President
  • Kevin Host – Chief Financial Officer

Publicly available information regarding founder involvement, broader executive leadership composition, or detailed governance philosophy is limited compared with larger publicly traded healthcare companies. Executive roles and governance details are based primarily on company filings, OTC disclosures, and investor communications.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $217.50
B
AAPL NASDAQ $304.91
B
AVGO NASDAQ $416.08
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $113.26
Top Financial Stocks
See All »
B
B
JPM NYSE $362.04
B
V NYSE $362.82
Top Energy Stocks
See All »
B
ENB NYSE $51.57
B
ENB.TO TSX $71.55
Top Health Care Stocks
See All »
B
LLY NYSE $1,215.02
B
JNJ NYSE $259.80
B
ABBV NYSE $250.09
Top Real Estate Stocks
See All »
B
PLD NYSE $139.50
B
EQIX NASDAQ $1,032.40